Literature DB >> 19776705

Turning laboratory findings into therapy: a marathon goal that has to be reached.

Beatrix Kotlan1, David F Stroncek, Francesco M Marincola.   

Abstract

The mission of translational research involves difficult tasks to be accomplished for its ultimate goal, i.e., the introduction of novel, effective therapeutic strategies in the clinic to diminish human suffering and cure life-threatening diseases. Translational research (also referred to as translational medicine) facilitates the translation of investment in biomedical research into successful medical treatment. This includes the transfer of diagnostic and therapeutic advances by proving their efficacy in large evidence-based trials. Through the study of humans novel insights about disease are brought back to the laboratory to identify new, observation-based strategies. This "two-way road" ("bench to bedside and bedside to bench") process includes formulating guidelines for drug development and principles for new therapeutic strategies; initiating clinical investigations that provide the biological basis for new therapies, and related clinical trials; defining therapeutic targets and clinical endpoints. It requires a systematic approach beginning with specimen sampling, patient data collection, laboratory investigations, data analysis, preclinical testing, clinical trials, treatment efficacy monitoring, and finally the evaluation of therapeutic result. The marathon well symbolizes the enormous efforts undertaken by clinicians, scientists, regulators, ethicists, patient advocates, drug developers, and others, coordinately attempting to overcome obstacles along this road toward the final "marathon goal in medicine".

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776705      PMCID: PMC3528796     

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  64 in total

Review 1.  What's next in translational medicine?

Authors:  Bruce H Littman; Linda Di Mario; Mario Plebani; Francesco M Marincola
Journal:  Clin Sci (Lond)       Date:  2007-02       Impact factor: 6.124

Review 2.  The immunologic constant of rejection.

Authors:  Ena Wang; Andrea Worschech; Francesco M Marincola
Journal:  Trends Immunol       Date:  2008-05-03       Impact factor: 16.687

3.  Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy.

Authors:  Stefan Ambs; Francesco M Marincola; Magdalena Thurin
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

4.  Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.

Authors:  K H Lee; E Wang; M B Nielsen; J Wunderlich; S Migueles; M Connors; S M Steinberg; S A Rosenberg; F M Marincola
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 5.  The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.

Authors:  Jeremy Holmes; Lindsay Hemmett; Susan Garfield
Journal:  Eur J Health Econ       Date:  2005-03

6.  Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

Authors:  J N Cormier; M L Salgaller; T Prevette; K C Barracchini; L Rivoltini; N P Restifo; S A Rosenberg; F M Marincola
Journal:  Cancer J Sci Am       Date:  1997 Jan-Feb

7.  A genomic- and proteomic-based hypothesis on the eclectic effects of systemic interleukin-2 administration in the context of melanoma-specific immunization.

Authors:  Monica C Panelli; Brian Martin; Dirk Nagorsen; Ena Wang; Kina Smith; Vladia Monsurro; Francesco M Marincola
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

8.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Authors:  Damien Chaussabel; Charles Quinn; Jing Shen; Pinakeen Patel; Casey Glaser; Nicole Baldwin; Dorothee Stichweh; Derek Blankenship; Lei Li; Indira Munagala; Lynda Bennett; Florence Allantaz; Asuncion Mejias; Monica Ardura; Ellen Kaizer; Laurence Monnet; Windy Allman; Henry Randall; Diane Johnson; Aimee Lanier; Marilynn Punaro; Knut M Wittkowski; Perrin White; Joseph Fay; Goran Klintmalm; Octavio Ramilo; A Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

9.  Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms.

Authors:  Frederic Lehmann; Denis Lacombe; Patrick Therasse; Alexander MM Eggermont
Journal:  J Transl Med       Date:  2003-08-07       Impact factor: 5.531

10.  Translational Medicine: A two-way road.

Authors:  Francesco M Marincola
Journal:  J Transl Med       Date:  2003-07-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.